India to United Arab Emirates: Docusate Export Trade Route

The India to United Arab Emirates Docusate corridor is one of India's established pharmaceutical export routes, with 1 shipments documented worth a combined $12.2K USD. The route is dominated by SAGA LIFESCIENCES LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's docusate manufacturing sector.

Across 1 active suppliers, the average shipment value stands at $12.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with docusate's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 32 days port-to-port. The route has recorded an annual growth rate of 20.9%, placing it at rank #6 among India's top docusate export destinations globally.

On the import side, key buyers of Indian docusate in United Arab Emirates include NA. NA is the single largest importer with 1 shipments valued at $12.2K USD.

India's docusate exports to United Arab Emirates are driven primarily by a handful of large-scale manufacturers. SAGA LIFESCIENCES LIMITED with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in United Arab Emirates benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — SAGA LIFESCIENCES LIMITED — together account for 100% of total trade value on this route. The average shipment value of $12.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

On the buying side, NA is the largest importer with 1 shipments worth $12.2K USD — representing 100% of all docusate imports from India on this route.